Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Related Articles by Review for PubMed (Select 16221067)

1.

Vaccine prospects for amebiasis.

Chaudhry OA, Petri WA Jr.

Expert Rev Vaccines. 2005 Oct;4(5):657-68. Review.

PMID:
16221067
2.

Host-pathogen interaction in amebiasis and progress in vaccine development.

Huston CD, Petri WA Jr.

Eur J Clin Microbiol Infect Dis. 1998 Sep;17(9):601-14. Review.

PMID:
9832261
3.

Entamoeba histolytica: from adherence to enteropathy.

Ravdin JI.

J Infect Dis. 1989 Mar;159(3):420-9. Review.

PMID:
2536786
4.

Prospect for an Entamoeba histolytica Gal-lectin-based vaccine.

Gaucher D, Chadee K.

Parasite Immunol. 2003 Feb;25(2):55-8. Review.

PMID:
12791100
5.

Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.

Miller-Sims VC, Petri WA Jr.

Curr Opin Immunol. 2002 Oct;14(5):549-52. Review.

PMID:
12183151
6.

Progress towards development of a vaccine for amebiasis.

Stanley SL Jr.

Clin Microbiol Rev. 1997 Oct;10(4):637-49. Review.

7.

Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI. Entamoeba histolytica: parasite-host interactions.

Stanley SL Jr, Reed SL.

Am J Physiol Gastrointest Liver Physiol. 2001 Jun;280(6):G1049-54. Review.

8.

Vaccines for amoebiasis: barriers and opportunities.

Stanley SL Jr.

Parasitology. 2006;133 Suppl:S81-6. Review.

PMID:
17274850
9.

Role of mucosal secretory immunity in the development of an amebiasis vaccine.

Ravdin JI, Kelsall BL.

Am J Trop Med Hyg. 1994;50(5 Suppl):36-41. Review.

PMID:
8203722
10.
11.

Protective immunity to amebiasis: new insights and new challenges.

Stanley SL Jr.

J Infect Dis. 2001 Aug 15;184(4):504-6. Epub 2001 Jul 6. Review.

12.

Adherence-blocking vaccine for amebiasis.

Petri WA Jr, Chaudhry O, Haque R, Houpt E.

Arch Med Res. 2006 Feb;37(2):288-91. Review.

PMID:
16380334
13.

The role of the secretory immune response in the infection by Entamoeba histolytica.

Carrero JC, Cervantes-Rebolledo C, Aguilar-Díaz H, Díaz-Gallardo MY, Laclette JP, Morales-Montor J.

Parasite Immunol. 2007 Jul;29(7):331-8. Review.

PMID:
17576362
14.

Amebiasis: host-pathogen biology.

Sepúlveda B.

Rev Infect Dis. 1982 Nov-Dec;4(6):1247-53. Review.

PMID:
6296964
15.

The dynamic interdependence of amebiasis, innate immunity, and undernutrition.

Verkerke HP, Petri WA Jr, Marie CS.

Semin Immunopathol. 2012 Nov;34(6):771-85. doi: 10.1007/s00281-012-0349-1. Epub 2012 Nov 1. Review.

16.

Recent progress in vaccines for amebiasis.

Snow MJ, Stanley SL Jr.

Arch Med Res. 2006 Feb;37(2):280-7. Review.

PMID:
16380333
17.

Molecular mechanisms of pathogenesis in amebiasis.

Das P, Debnath A, Muñoz ML.

Indian J Gastroenterol. 1999 Oct-Nov;18(4):161-6. Review.

PMID:
10531719
18.

Review of the human immune mechanisms directed against Entamoeba histolytica.

Salata RA, Ravdin JI.

Rev Infect Dis. 1986 Mar-Apr;8(2):261-72. Review.

PMID:
2871622
19.

Amebic colitis: new insights into pathogenesis and treatment.

Bercu TE, Petri WA, Behm JW.

Curr Gastroenterol Rep. 2007 Oct;9(5):429-33. Review.

PMID:
17991346
20.

The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.

Campos-Rodríguezp R, Jarillo-Luna A.

Parasite Immunol. 2005 Jan-Feb;27(1-2):1-8. Review.

PMID:
15813717
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk